CUMULUS CELLS GENE EXPRESSION PROFILE FOLLOWING CONTROLLED OVARIAN STIMULATION WITH HP-HMG OR rFSH IN A GnRH ANTAGONIST PROTOCOL: NEW INDICATORS OF OVARIAN MICROENVIRONMENT HEALTH

被引：0
|
作者：
Dechaud, H.
Assou, S.
Moussaddykine, S.
Van den Abbeel, E.
Aasted, H.
Hamamah, S.
机构：
[1] Hop St Eloi, Inst Rech Biotherap, CHU Montpellier, Montpellier, Herault, France
[2] Hop Arnaud de Villeneuve, Dept Reprod Biol, CHU Montpellier, Montpellier, Herault, France
[3] INSERM, U1040, Montpellier, Herault, France
[4] UZ Gent, Ghent, Belgium
[5] Ferring Pharmaceut, Global Clin Res & Dev Reprod Med, Copenhagen, Denmark
来源：
FERTILITY AND STERILITY | 2011年 / 96卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2011.07.987
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S257 / S258
页数：2
相关论文
共 28 条
  • [21] Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
    Khair, Andrew
    Brown, Tray
    Markert, Marie
    Barsoe, Carsten Rodseth
    Daftary, Gaurang S. S.
    Heiser, Patrick W. W.
    PHARMACOECONOMICS-OPEN, 2023, 7 (05) : 851 - 860
  • [22] Type of gonadotropin used during controlled ovarian stimulation induces differential gene expression in human cumulus cells: A randomized study
    Cruz, Maria
    Requena, Antonio
    Agudo, David
    Antonio Garcia-Velasco, Juan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 124 - 133
  • [23] LONG-ANTAGONIST PROTOCOL; LUTEAL ADMINISTRATION OF A SINGLE DOSE OF DEGARELIX (LONG-ACTING GNRH-ANTAGONIST) FOR CONTROLLED OVARIAN STIMULATION. A NEW PROTOCOL FOR IVF.
    Papanikolaou, E.
    Timotheou, E.
    Tatsi, P.
    Chartomatsidou, T.
    Najdecki, R.
    FERTILITY AND STERILITY, 2018, 110 (04) : E336 - E337
  • [24] Gene expression profile in human cumulus cells stimulated with purified FSH (HMG) or recombinant FSH (recFSH) combined with gonadotropin-releasing hormone agonist (GnRH-a) or antagonist (GnRH-ant).
    Hamamah, S.
    Loup, V.
    Reme, T.
    De Vos, J.
    Dechaud, H.
    Gasca, S.
    FERTILITY AND STERILITY, 2007, 88 : S35 - S35
  • [25] COST COMPARISON OF HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLE-STIMULATING HORMONE (RFSH) FOR CONTROLLED OVARIAN STIMULATION IN US HIGH-RESPONDER PATIENTS BASED ON THE MEGASET-HR TRIAL.
    Khair, Andrew F.
    Brown, Tray
    Markert, Marie
    Samuelsen, Carl H.
    Barsoe, Carsten
    Daftary, Gaurang S.
    Heiser, Patrick W.
    FERTILITY AND STERILITY, 2021, 116 (03) : E267 - E267
  • [26] PGR and PTX3 gene expression in cumulus cells from obese and normal weighting women after administration of long-acting recombinant follicle-stimulating hormone for controlled ovarian stimulation
    Papler, Tanja Burnik
    Bokal, Eda Vrtacnik
    Zmrzljak, Ursula Prosenc
    Stimpfel, Martin
    Lagana, Antonio Simone
    Ghezzi, Fabio
    Jancar, Nina
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 299 (03) : 863 - 871
  • [27] PGR and PTX3 gene expression in cumulus cells from obese and normal weighting women after administration of long-acting recombinant follicle-stimulating hormone for controlled ovarian stimulation
    Tanja Burnik Papler
    Eda Vrtačnik Bokal
    Uršula Prosenc Zmrzljak
    Martin Stimpfel
    Antonio Simone Laganà
    Fabio Ghezzi
    Nina Jančar
    Archives of Gynecology and Obstetrics, 2019, 299 : 863 - 871
  • [28] Comparing the gene expression profile of human endometrial cells between day 2 (LH+2) and day 7 (LH+7) after the LH surge, during natural cycles of women scheduled for controlled ovarian stimulation.
    Terras, K.
    Gasca, S.
    Zhioua, F.
    Hfaiedh, T.
    Hamdoun, L.
    Hamamah, S.
    FERTILITY AND STERILITY, 2007, 88 : S194 - S194
123